Analyst David Saxon of Needham reiterated a Buy rating on ZimVie Inc (ZIMV – Research Report), with a price target of $23.00.
David Saxon has given his Buy rating due to a combination of factors that suggest ZimVie Inc is poised for future improvement. Despite the company missing consensus revenue expectations in the fourth quarter of 2024, its adjusted EBITDA met forecasts, indicating a level of financial stability.
Furthermore, while there was noted weakness in the implants and scanners product groups during the quarter, management has observed a normalization in the domestic implant market in the first quarter of 2025. This stabilization, along with anticipated margin improvements, supports the optimistic outlook for ZimVie’s performance, reinforcing the Buy recommendation.
Questions or Comments about the article? Write to editor@tipranks.com